REGENXBIO
IPOPublic · Rockville, United States · Founded 2008 · $30.0M raised
- Headquarters
- Rockville, Maryland
- Employees
- 201–500
- Founded
- 2008
- Business Model
- B2B
- Website
- regenxbio.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series C
- Rounds
- 1
- Type
- Public
About
REGENXBIO is a clinical-stage gene therapy company leveraging its NAV Technology Platform to develop treatments for rare and serious diseases.
Summary
REGENXBIO is a Biotech company based in Rockville, United States, founded in 2008. It has raised $30.0M in total across 1 round. Investors include Venrock and Fidelity Biosciences.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2015
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.